In recent years, the rapid advancement of artificial intelligence (AI) and machine learning (ML) technologies has sparked a wave of innovation across various sectors, particularly in life sciences. ML technologies have...more
2/25/2025
/ Artificial Intelligence ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Machine Learning ,
Medical Devices ,
Patents ,
Popular ,
Regulatory Requirements ,
Risk Management ,
Trade Secrets ,
USPTO
Artificial Intelligence (AI) in intellectual property is as big – and as fast-changing – a topic as ever. On January 14, 2025, the U.S. Patent and Trademark Office (USPTO) published an Artificial Intelligence Strategy...more
1/27/2025
/ Artificial Intelligence ,
Data Privacy ,
Data Protection ,
Executive Orders ,
Innovative Technology ,
Intellectual Property Protection ,
Inventors ,
Machine Learning ,
Patent Trial and Appeal Board ,
Patents ,
Trademarks ,
USPTO
As expected, the United States Patent and Trademark Office (USPTO) is raising its fees this year, effective January 19, 2025. However, the USPTO is doing something a little unusual this time—they’re raising the cost of filing...more
The integration of artificial intelligence (AI) and machine learning (ML) into the life sciences field has created exciting new opportunities for advancements in diagnostics, therapeutics, and personalized medicine. However,...more
The United States Patent and Trademark Office (USPTO) issued an important update to its guidance on patent subject matter eligibility under 35 U.S.C. § 101, specifically focusing on artificial intelligence (AI) and other...more
7/26/2024
/ Abstract Ideas ,
Artificial Intelligence ,
Corporate Counsel ,
Emerging Technology Companies ,
Enforcement ,
Inventions ,
Patent Infringement ,
Patent-Eligible Subject Matter ,
Patents ,
Technology Sector ,
USPTO
The United States Patent and Trademark Office (USPTO) has issued a pivotal guidance document, effective April 11, on the use of Artificial Intelligence (AI) tools within patent and trademark practices. This guidance signals a...more
Pursuant to President Biden’s October 2023 executive order on AI, on April 11, 2024, the United States Patent and Trademark Office (USPTO or Office) published “Guidance on Use of Artificial Intelligence-Based Tools in...more
4/23/2024
/ Artificial Intelligence ,
Biden Administration ,
Confidential Information ,
Executive Orders ,
Exports ,
Inventions ,
Inventors ,
Licensing Rules ,
Machine Learning ,
New Guidance ,
Patents ,
Policies and Procedures ,
Regulatory Agenda ,
Regulatory Requirements ,
USPTO
Overview of Subject Matter Eligibility Challenges Computer-based -
inventions – especially in the machine learning (ML), bioinformatics, and artificial intelligence (AI) fields – are susceptible to subject matter...more
In our first blog in this multi-part series, we explored key considerations for protecting artificial intelligence (“AI”) inventions in biotech and synthetic biology. In this part 2 of the series, we will examine some key...more
1/30/2020
/ Algorithms ,
Artificial Intelligence ,
Biotechnology ,
Computer-Related Inventions ,
Intellectual Property Protection ,
Life Sciences ,
Machine Learning ,
Patent Applications ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
USPTO
Artificial Intelligence (AI) inventions have aided development in nearly every industry, but perhaps none more so than synthetic biology. For synthetic biology researchers, AI has developed into a vital tool to create cutting...more
9/30/2019
/ Analytics ,
Artificial Intelligence ,
Biotechnology ,
Computer-Related Inventions ,
CRISPR ,
Drug Compounding ,
Intellectual Property Protection ,
Machine Learning ,
Patent Prosecution ,
Patents ,
Pharmaceutical Patents ,
Popular ,
Robotics ,
Software Patents ,
USPTO
On June 19, 2017, the U.S. Patent and Trademark Office (USPTO) announced that it would be extending the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immunotherapy to be examined...more
Effective June 29, 2016, the United States Patent and Trademark Office (USPTO) implemented a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy. The Cancer Immunotherapy...more